AACR20: a nanomedicine news round up
The American Association of Cancer Research Virtual Annual Meeting II (AACR20) took place on the 22–24 June 2020. Many new fields in oncological research were showcased, with nanomedicine and nanotechnology featuring in some of the most up and coming topics. A few of my favorite presentations from these important areas of oncology are summarized below. Immunotherapy in cancer Natural killer cell nanoengagers for improved targeted chemoimmunotherapy Researchers from the University of North Carolina at Chapel Hill (NC, USA) have recently been focusing on the activation of natural killer (NK) cells in cancer immunotherapy. To do this, they propose to simultaneously co-active more than one NK cell...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!
